levodopa has been researched along with pd 98059 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Kato, Y; Koshimura, K; Murakami, Y; Tanaka, J | 1 |
| Evert, BO; Klockgether, T; Schaupp, M; Schulz, JB; Schwarz, CS; Seyfried, J; Wüllner, U | 1 |
3 other study(ies) available for levodopa and pd 98059
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Effects of dopamine and L-DOPA on survival of PC12 cells.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Calcium; Calcium Channel Blockers; Cell Differentiation; Cell Survival; Culture Media, Serum-Free; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Flavonoids; Intracellular Fluid; Levodopa; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Monoamine Oxidase Inhibitors; Nerve Growth Factor; Neuroprotective Agents; PC12 Cells; Rats; Receptors, Dopamine D1 | 2000 |
Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status.
Topics: Animals; Antioxidants; Calcium-Calmodulin-Dependent Protein Kinases; Cell Survival; Dopamine Agents; Doxycycline; Enzyme Inhibitors; Flavonoids; Gene Dosage; Gene Expression Regulation; Glutathione; Levodopa; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Oxidation-Reduction; Oxidative Stress; PC12 Cells; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Rats | 2003 |